Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com

onc201

First-in-Human clinical trial of oral ONC201 in patients with refractory solid tumors

Clin Cancer Res. 2017 PMID: 28331050

View Publication